Screener
Heron Therapeutics HRTX Q1 2025 earnings
Reported May 6, 2025 · Before market open
Revenue$38.9MBeat by $653.0K
EPS$0.01Beat by $0.02
Revenue estimate$38.3M
EPS estimate-$0.01
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$37.5M
EPS estimate-$0.03
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Heron Therapeutics report Q1 2025 earnings?
- Heron Therapeutics (HRTX) reported Q1 2025 earnings on May 6, 2025 before market open.
- What were Heron Therapeutics's Q1 2025 revenue and EPS?
- Heron Therapeutics reported revenue of $38.9M and eps of $0.01 for Q1 2025.
- Did Heron Therapeutics beat estimates in Q1 2025?
- Revenue beat the consensus estimate of $38.3M by $653.0K. EPS beat the consensus estimate of $-0.01 by $0.02.
- How did Heron Therapeutics's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 12.2% from $34.7M a year earlier.
- Where can I find Heron Therapeutics's Q1 2025 SEC filings?
- You can read the 8-K earnings release (0000950170-25-063973) and the 10-Q periodic report (0000950170-25-063971) directly on SEC EDGAR. The filing index links above go to sec.gov.
